Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | — CALL | KALVISTA PHARMACEUTICALS INC | — | 290,600.0 | $4.7M | 0.65% | NEW | — | $16.15 | — |
| 42 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 394,650.0 | $4.5M | 0.62% | NEW | — | $11.31 | -37.1% |
| 43 | — CALL | FULCRUM THERAPEUTICS INC | — | 391,900.0 | $4.4M | 0.62% | NEW | — | $11.31 | — |
| 44 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 303,939.0 | $4.0M | 0.55% | -3K | -1.0% | $13.12 | -65.2% |
| 45 | CCCC | C4 THERAPEUTICS INC | Healthcare | 1,994,224.0 | $3.8M | 0.53% | +97K | +5.1% | $1.91 | +86.4% |
| 46 | — | SURROZEN INC | — | 157,323.0 | $3.6M | 0.49% | NEW | — | $22.60 | — |
| 47 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 307,540.0 | $3.5M | 0.49% | +141K | +85.1% | $11.43 | +24.3% |
| 48 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 94,983.0 | $3.4M | 0.48% | +15K | +18.7% | $36.29 | -24.9% |
| 49 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 398,167.0 | $3.4M | 0.47% | NEW | — | $8.46 | +51.1% |
| 50 | — | ABEONA THERAPEUTICS INC | — | 627,738.0 | $3.3M | 0.46% | -367K | -36.9% | $5.27 | — |
| 51 | TELA | TELA BIO INC | Healthcare | 2,647,512.0 | $3.1M | 0.43% | -135K | -4.9% | $1.18 | -23.3% |
| 52 | QURE | UNIQURE NV | Healthcare | 126,047.0 | $3.0M | 0.42% | -329K | -72.3% | $23.93 | +16.0% |
| 53 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 36,124.0 | $3.0M | 0.41% | NEW | — | $81.88 | -20.4% |
| 54 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 34,589.0 | $2.7M | 0.37% | NEW | — | $77.81 | +8.6% |
| 55 | — CALL | ULTRAGENYX PHARMACEUTICAL IN | — | 110,000.0 | $2.5M | 0.35% | -418K | -79.2% | $23.00 | — |
| 56 | NXTC | NEXTCURE INC | Healthcare | 176,057.0 | $2.5M | 0.35% | NEW | — | $14.19 | -31.4% |
| 57 | — | ELUTIA INC | — | 2,751,314.0 | $1.9M | 0.27% | -100K | -3.5% | $0.69 | — |
| 58 | SION | SIONNA THERAPEUTICS INC | Healthcare | 41,460.0 | $1.7M | 0.24% | -67K | -61.9% | $41.14 | +4.0% |
| 59 | CTMX | CYTOMX THERAPEUTICS INC | Healthcare | 385,974.0 | $1.6M | 0.23% | NEW | — | $4.26 | -11.3% |
| 60 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 357,387.0 | $1.4M | 0.20% | NEW | — | $4.00 | -1.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%